Video: DNA methylation and improved detection of cervical pre-cancers in screening, diagnosis and post-treatment management
This page is part of a series of resources dedicated to the state-of-the-art of HPV testing.
Get a full overview of our resources here.
In this short video you will find out how DNA methylation plays a crucial role in cancer development. And how the PreCursor-M+ assay, measuring the hypermethylation of two host cell genes associated with cervical carcinoma and advanced transforming cervical precancer, can help clinicians distinguish pre-malignant lesions likely to evolve into cancer from lesions that will spontaneously regress.
Related articles
EUROGIN 2024 – key takeaway messages
The annual EUROGIN conference covers a dense scientific program on the topic of Human papillomavirus (HPV) and its associated cancers, always with a...
Scientific poster – Inter- and intra-laboratory reproducibility of the AmpFire® HPV Screening 16/18/HR assay
This poster summarizes the investigation of the reproducibility (within a laboratory and between laboratories) of the AmpFire HPV Screening 16/18/HR...
A risk-based approach for post-treatment detection of recurrent CIN
This article describes how HPV genotyping and DNA methylation analysis can help discriminate women in need of re-treatment from those who can be...
Better care for pregnant women diagnosed with precancerous cervical lesions
Cervical cancer is the most common malignancy of the female reproductive tract during pregnancy occurring in 1 to 10 per 10 000 pregnancies with an...
Cervical cancer screening being reviewed – the role of distinguishing individual HPV genotypes
Cervical screening guidelines are being reviewed and changed in response to new evidence as it becomes available. At EU level the cancer screening...
Improved triage with FAM19A4/miR124-2 methylation analysis - clinical assurance thanks to objective and reliable results
Studies demonstrate FAM19A4/miR124-2 methylation can be considered as an alternative to cytology as follow-up test for hrHPV positive women given its...
EUROGIN 2023 - Shared challenges to the implementation of HPV screening and diagnostics from research to practice
The keynote lectures by prominent experts in their respective fields at the recent Eurogin 2023 Conference in Bilbao, Spain, once again gave a good...
The interest of SPF10 PCR-based methods for HPV DNA detection in FFPE samples
The past decades, prevalence studies have been done using FFPE (Formalin-fixed-paraffin-embedded) tissue specimens to investigate HPV association with...
Booklet: The Art of Accuracy - Improved triage with FAM19A4/miR124-2 methylation analysis
How does FAM19A4/miR124-2 methylation analysis improve hrHPV positive patient triage and how does it allow a wait-and-see policy? We have prepared an...
Webinar: First void urine & HPV genotyping - Two essential tools to monitor the impact of HPV vaccination programs
The enormous potential of a first void – or initial stream – urine sample becomes evident when we understand it’s composition. In fact, in the case of...
Interview: Urine self sampling could change the world of testing, not only for HPV but also for other oncology markers
Our own Rebecca Millecamps, Marketing Manager at Fujirebio, was interviewed for the podcast series 'Molecules, microbes and multiomics' about the...
INNO-LiPA® HPV Genotyping Extra II for use on self-collected first-void urine samples
HPV (Human Papilloma Virus) is a sexually transmitted virus. Certain genotypes of this virus are known to cause cancers in both men and women, but...
Powered by Bioz
